Open AccessClinical experience with the interleukin-1β blocker canakinumab in patients with chronic tophaceous gout: abolishment of arthritis and prevention of exacerbations when allopurinol is used
Author(s) -
М. С. Елисеев,
О. В. Желябина,
М. В. Мукагова,
Е. Л. Насонов
Publication year - 2015
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2015-2-16-22
Subject(s) - medicine , canakinumab , gout , allopurinol , arthritis , colchicine , anakinra , inflammatory arthritis , rheumatology , visual analogue scale , exacerbation , surgery , gastroenterology , disease